E-cadherin expression by breast carcinoma cells was found to be regulated epigenetically via hypermethylation of the promoter region which provides cancer cell with flexibility to switch between EMT at primary tumor site and mesenchymal epithelial reverting transition (MErT) at the site of metastasis [9]. Here, CDH1 is linked to neoplasm.